|
(9) Biophysical Description of Age and Dose Dependent Changes to Dendritic Morphology that Impact Cognition following Radiation Cancer Therapy
|
1R01CA208526-01
|
$484,047
|
$484,047
|
CUCINOTTA, FRANCIS
|
UNIVERSITY OF NEVADA LAS VEGAS
|
|
(PQ #4) Single cell barcoding for studies of study clonal evolution in glioblasto
|
5R01CA190121-03
|
$332,000
|
$332,000
|
VERHAAK, ROELAND
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
(PQ 9) Synaptic basis of deficits in attention and executive function following cranial radiation
|
1R01CA208535-01
|
$536,390
|
$536,390
|
GROSSHANS, DAVID
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
(PQA1) The antipsychotic thioridazine protects against medulloblastoma (MB): volu
|
5R01CA185039-03
|
$373,436
|
$373,436
|
JAN, LILY
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
(PQB4) Stochastic Profiling of Functional Single-Cell States Within Solid Tumors
|
5R01CA194470-02
|
$464,569
|
$153,308
|
JANES, KEVIN
|
UNIVERSITY OF VIRGINIA
|
|
(PQB5) Reconstruction of Evolutionary Networks using Cross-Sectional Genomic Data
|
5R01CA185486-03
|
$517,690
|
$258,845
|
RABADAN, RAUL
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
(PQB5)Molecular Wiring and Therapeutic Targeting of EGFR and PDGFR Signaling Netw
|
7R01CA185137-03
|
$918,872
|
$918,872
|
CHAREST, ALAIN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
(PQD-5) Patient derived orthotopic xenograft models for drug response prediction
|
5R01CA185402-03
|
$322,828
|
$322,828
|
LI, XIONAN
|
BAYLOR COLLEGE OF MEDICINE
|
|
(PQD3) Mechanisms of prolonged initial disease-free survival in glioblastoma
|
5R01CA184320-03
|
$738,276
|
$738,276
|
SARKARIA, JANN
|
MAYO CLINIC ROCHESTER
|
|
5-hydroxymethylcytosine in human cancer
|
5R01CA160965-05
|
$394,250
|
$197,125
|
PFEIFER, GERD
|
VAN ANDEL RESEARCH INSTITUTE
|
|
A Bayesian Framework for Inter-Modality Deformable Image Registration Evaluation
|
5K01CA181292-04
|
$119,534
|
$29,884
|
CASTILLO, RICHARD
|
UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
|
|
A causal role for asymmetric cell division defects in glioma initiation
|
4R01CA164746-05
|
$320,588
|
$320,588
|
PETRITSCH, CLAUDIA
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
A CEST-MRI Reporter Gene for Image Guided Oncolytic Virotherapy
|
1R01CA203873-01
|
$379,150
|
$379,150
|
FARRAR, CHRISTIAN
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
A clinically-relevant anti-CD27 agonist antibody as a vaccine adjuvant for brain tumor immunotherapy
|
1F31CA210535-01
|
$31,686
|
$31,686
|
RICCIONE, KATHERINE
|
DUKE UNIVERSITY
|
|
A Genetic Toolbox for the Identification and Interrogation of Tumor Cells of Origin, Propagation, and Recurrence From Patient-derived Oncogenic Drivers
|
1R33CA202900-01
|
$418,128
|
$418,128
|
BREUNIG, JOSHUA
|
CEDARS-SINAI MEDICAL CENTER
|
|
A high content screen dissecting ciliogenesis and oncogenic Hedgehog signaling
|
1R01CA181231-01A1
|
$362,569
|
$181,285
|
REITER, JEREMY
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
A Mechanistic Understanding of Neuronal Activity Promotion of High-Grade Glioma Growth through Activity-Regulated Secretion of Neuroligin-3
|
5F31CA200273-02
|
$43,576
|
$43,576
|
VENKATESH, HUMSA
|
STANFORD UNIVERSITY
|
|
A Novel Approach to Treating Glioblastoma through Activation of the Liver X Recep
|
5F31CA186668-03
|
$34,293
|
$34,293
|
VILLA, GENARO
|
LUDWIG INSTITUTE FOR CANCER RES LTD
|
|
A novel pathway to clear cells of misfolded proteins
|
ZIA BC 011628
|
$189,172
|
$141,879
|
Walters, Kylie
|
CCR (NCI)
|
|
A novel strategy to overcome resistance in Temozolomide-Refractory Glioblastomas
|
5R21CA195149-02
|
$199,553
|
$199,553
|
HERGENROTHER, PAUL
|
UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN
|
|
A NOVEL TARGETED DELIVERY SYSTEM FOR CANCER TREATMENT AND DIAGNOSIS
|
5R44CA183287-03
|
$435,490
|
$435,490
|
BRAMHILL, DAVID
|
ENDURX PHARMACEUTICALS, INC.
|
|
A Phase I Study of Intracranially Administered Carboxylesterase-Expressing Neural Stem Cells in Combination with Intravenous Irinotecan in Patients with Recurrent High Grade Gliomas
|
5R01CA198076-02
|
$618,770
|
$618,770
|
PORTNOW, JANA
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
A Predictive Prognostic Model for Glioblastoma Multiforme
|
4R01CA157553-05
|
$439,111
|
$439,111
|
BUI, ALEX
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
A Prospective Study of Social Competence in Pediatric Brain Tumor Survivors
|
4K07CA178100-04
|
$130,495
|
$130,495
|
HOCKING, MATTHEW
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
AARP prospective study of diet and cancer
|
ZIA CP010196-03152
|
$1,229,987
|
$61,499
|
Sinha, Rashmi
|
DCEG (NCI)
|
|
Abramson Cancer Center Support Grant
|
2P30CA016520-40
|
$7,975,543
|
$159,511
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-40S1
|
$31,250
|
$625
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-40S2
|
$499,967
|
$9,999
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-40S3
|
$200,000
|
$4,000
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Academic-Industrial Partnership to Develop Clinical Brain Cancer Imaging
|
4R01CA166171-04
|
$432,600
|
$432,600
|
ZHOU, JINYUAN
|
JOHNS HOPKINS UNIVERSITY
|
|
Adaptive resistance to HIF1a inhibition in hypoxia
|
1R01CA207377-01
|
$352,242
|
$116,240
|
QIAN, ZHENG DAVID
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Adult Brain Tumor Consortium (ABTC)
|
3UM1CA137443-07S1
|
$250,000
|
$250,000
|
GROSSMAN, STUART
|
JOHNS HOPKINS UNIVERSITY
|
|
Advanced Development and Validation of 3 Dimensional Spheroid Culture of Primary Cancer Cells using Nano3D Technology
|
1R33CA206949-01
|
$501,426
|
$250,713
|
SPICER, TIMOTHY
|
SCRIPPS FLORIDA
|
|
AIDS Malignancy Consortium (AMC)
|
5UM1CA121947-10
|
$21,619,997
|
$5,404,999
|
MITSUYASU, RONALD
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-03S1
|
$1,595,651
|
$39,891
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-03S2
|
$550,000
|
$13,750
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-03S3
|
$750,000
|
$18,750
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
5U10CA180821-03
|
$9,068,022
|
$226,701
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
An investigation of Radial Glia as the source of Ependymoma Stem Cells
|
5R01CA129541-11
|
$199,044
|
$99,522
|
GILBERTSON, RICHARD
|
UNIVERSITY OF CAMBRIDGE
|
|
Analysis of STAG2 Inactivation and Aneuploidy in Human Cancer
|
4R01CA169345-04
|
$322,663
|
$322,663
|
WALDMAN, TODD
|
GEORGETOWN UNIVERSITY
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,014,935
|
$91,344
|
Barr, Frederic
|
CCR (NCI)
|
|
Angiogenesis-targeting therapy for glioblastoma
|
3R01CA129371-09S1
|
$173,281
|
$173,281
|
BATCHELOR, TRACY
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Angiogenesis-targeting therapy for glioblastoma
|
4R01CA129371-09
|
$592,913
|
$592,913
|
BATCHELOR, TRACY
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
ANTI-PDZ DOMAIN ANTIBODIES ENHANCE THE EFFICACY OF RADIOTHERAPY
|
1R43CA210687-01
|
$216,853
|
$71,561
|
ROTI ROTI, JOE
|
MEDICAL GUIDANCE SYSTEMS, LLC
|
|
Anticancer Drug Pharmacology in Very Young Children
|
4R01CA154619-05
|
$433,475
|
$433,475
|
STEWART, CLINTON
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Apoptotic Proteins as Molecular Modulators of Stem Cell Fate
|
5R00CA178190-04
|
$249,000
|
$249,000
|
GAMA, VIVIAN
|
VANDERBILT UNIVERSITY
|
|
ATP-Dependent Chromatin Remodeling in Human Malignancy
|
4R01CA163915-05
|
$328,914
|
$82,229
|
CRABTREE, GERALD
|
STANFORD UNIVERSITY
|
|
ATR: a novel therapeutic target for medulloblastoma identified by its role in cerebellar development
|
5F30CA192832-02
|
$33,814
|
$33,814
|
LANG, YUN LONG
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Augmented homologous recombination as a mechanism of acquired temozolomide resistance in glioblastoma
|
1R21CA202403-01A1
|
$176,131
|
$176,131
|
BURMA, SANDEEP
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Autophagy as a microenvironmental regulator of tumorigenesis and resistance
|
5R01CA188404-03
|
$422,163
|
$422,163
|
DEBNATH, JAYANTA
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
Total relevant funding to Brain for this search: $194,189,633
|